[go: up one dir, main page]

AR047094A1 - Derivados de diarilmetil piperazina, sus preparaciones y sus usos - Google Patents

Derivados de diarilmetil piperazina, sus preparaciones y sus usos

Info

Publication number
AR047094A1
AR047094A1 ARP050100061A ARP050100061A AR047094A1 AR 047094 A1 AR047094 A1 AR 047094A1 AR P050100061 A ARP050100061 A AR P050100061A AR P050100061 A ARP050100061 A AR P050100061A AR 047094 A1 AR047094 A1 AR 047094A1
Authority
AR
Argentina
Prior art keywords
alkyl
cycloalkyl
nrc
diarilmetil
piperazina
Prior art date
Application number
ARP050100061A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31493012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR047094(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR047094A1 publication Critical patent/AR047094A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Reivindicacion 1: Un compuesto de formula (1), una sal aceptable para uso farmacéutico del mismo, diastereomeros, enantiomeros, o mezclas de los mismos: en la cual R1 se selecciona de alquilo C1-6, alquenilo C2-6, cicloalquilo C3-6 y cicloalquil C3- 6-alquilo C1-4, donde dichos alquilo C1-6, alquenilo C2-6, cicloalquilo C3-6, y cicloalquil C3-6-alquilo C1-4 se sustituyen opcionalmente con uno o más grupos seleccionados de -R, -NO2, -OR, -Cl, -Br, -I, -F, -CF3, -C(=O)R, -C(=O)OH, -NH2, -SH, - NHR, -NR2, -SR, -SO3H, -SO2R, -S(=O)R, -CN, -OH, -C(=O)OR, -C(=O)NR2, -NRC(=O)R y -NRC(=O)-OR, donde R es, independientemente, un H, cicloalquilo C3-6 o alquilo C1-6; R2 se selecciona de -H, alquilo C1-6 y cicloalquilo C3-6,donde dichos alquilo C1-6 y cicloalquilo C3-6 se sustituyen opcionalmente con uno o más grupos seleccionados de -OR, -Cl, -Br, -I, -F, -CF3, -C(=O)R, -C(=O)OH, -NH2, -SH, -NHR, -NR2, -SR, -SO3H, -SO2R, -S(=O)R, -CN, -OH, -C(=O)OR, -C(=O)NR2, -NRC(=O)R y -NRC(=O)-OR, donde R es, independientemente, un H, o alquilo C1-6; y R3 se selecciona de alquilo C1-6 y cicloalquilo C3-6, donde dichos alquilo C1-6 y cicloalquilo C3-6 se sustituyen opcionalmente con uno o más grupos seleccionados de: -OR, -Cl, -Br, -I, -F, -CF3, - C(=O)R, -C(=O)OH, -NH2, -SH, -NHR, -NR2, -SR, -SO3H, -SO2R, -S(=O)R, -CN, -OH, -C(=O)OR, -C(=O)NR2, -NRC(=O)R y -NRC(=O)-OR, donde R es, independientemente, un H, o alquilo C1-6.
ARP050100061A 2004-01-09 2005-01-07 Derivados de diarilmetil piperazina, sus preparaciones y sus usos AR047094A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0400027A SE0400027D0 (sv) 2004-01-09 2004-01-09 Diarylmethyl piperazine derivatives, preparations thereof and uses thereof

Publications (1)

Publication Number Publication Date
AR047094A1 true AR047094A1 (es) 2006-01-04

Family

ID=31493012

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050100061A AR047094A1 (es) 2004-01-09 2005-01-07 Derivados de diarilmetil piperazina, sus preparaciones y sus usos

Country Status (18)

Country Link
US (1) US20070293502A1 (es)
EP (1) EP1706393A1 (es)
JP (1) JP2007517873A (es)
KR (1) KR20060123446A (es)
CN (1) CN1926122A (es)
AR (1) AR047094A1 (es)
AU (1) AU2005204010A1 (es)
BR (1) BRPI0506702A (es)
CA (1) CA2552851A1 (es)
IL (1) IL176513A0 (es)
MX (1) MXPA06007664A (es)
NO (1) NO20063619L (es)
SA (1) SA05250441A (es)
SE (1) SE0400027D0 (es)
TW (1) TW200524609A (es)
UY (1) UY28715A1 (es)
WO (1) WO2005066148A1 (es)
ZA (1) ZA200605442B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1395567B1 (en) * 2001-05-18 2009-01-14 AstraZeneca AB 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
MX2007001240A (es) 2004-08-02 2007-03-23 Astrazeneca Ab Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
SI2041088T1 (sl) 2006-06-28 2014-05-30 Amgen Inc. Inhibitorji transporter-1 glicina
US20090291966A1 (en) * 2008-05-20 2009-11-26 Astrazeneca Ab Method Of Treating Anxious Major Depressive Disorder
KR101516703B1 (ko) * 2013-02-20 2015-05-04 김슬기 영아 시트 침대

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585209A5 (es) * 1973-06-29 1977-02-28 Cermol Sa
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
SE9504661D0 (sv) * 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) * 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
SE0101765D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds

Also Published As

Publication number Publication date
US20070293502A1 (en) 2007-12-20
TW200524609A (en) 2005-08-01
SE0400027D0 (sv) 2004-01-09
UY28715A1 (es) 2005-08-31
BRPI0506702A (pt) 2007-05-02
ZA200605442B (en) 2007-04-25
WO2005066148A1 (en) 2005-07-21
IL176513A0 (en) 2008-02-09
CN1926122A (zh) 2007-03-07
JP2007517873A (ja) 2007-07-05
KR20060123446A (ko) 2006-12-01
MXPA06007664A (es) 2006-09-04
EP1706393A1 (en) 2006-10-04
NO20063619L (no) 2006-10-09
AU2005204010A1 (en) 2005-07-21
CA2552851A1 (en) 2005-07-21
SA05250441A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
AR041895A1 (es) Derivados de 4 (fenil-piperazinil-metil) benzamida y sus usos para el tratamiento del dolor y desordenes gastrointestinales
ECSP034865A (es) Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas
CL2008002132A1 (es) Compuestos derivados de sulfonamidas, moduladores de trpm8; composiciones farmaceuticas que comprenden a dichos compuestos; y uso de dichos compuestos en el tratamiento del dolor neuropatico, dolor inflamatorio, ansiedad, depresion, hiperalgesia inflamatoria, entre otras.
AR044045A1 (es) Compuesto de piperidincarbonilpiperazina, composicion farmaceutica que lo comprende, su uso para la elaboracion de un medicamento y procedimiento para su preparacion
AR067757A1 (es) Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales.
AR067060A1 (es) Derivados de guanina policiclicos y sus metodos de uso
AR075892A1 (es) Derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen
AR044342A1 (es) Derivados de bencimidazol
AR016499A1 (es) Compuestos de pirrolo[2,3-d]pirimidina, composiciones y procesos para su uso en medicina.
AR085544A1 (es) Inhibidores triciclicos fusionados dobles de las cdk 4/6 y de la flt3
AR062677A1 (es) Derivados de biaril-sulfonamida, procesos de produccion y composiciones farmaceuticas que los comprenden
AR066799A1 (es) Antagonistas para el receptor ccr2 y sus usos
AR048213A1 (es) 1-(4-mono-y di-halometilsulfonilfenil)-2-acilamino-fluorpropanoles analogos al florfenicol
AR047094A1 (es) Derivados de diarilmetil piperazina, sus preparaciones y sus usos
AR030243A1 (es) Carboxamidas heterociclicas, composiciones farmaceuticas, uso de las mismas para la manufactura de un medicamento antiviral y metodo in vitro para inhibir el adn polimerasa viral
CR9507A (es) Sulfonamidas de diarisulfona y sus usos
AR084251A1 (es) Inhibidores dimericos de las iap
AR042887A1 (es) Derivados de diarilmetiden piperidina preparaciones y usos de los mismos
UY29818A1 (es) Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos
AR046769A1 (es) Composiciones farmaceuticas
AR047093A1 (es) Derivados de diarilmetiliden piperidina, sus preparaciones y sus usos
AR047092A1 (es) Derivados de diarilmetilidenpiperidina, sus preparaciones y sus usos
AR054747A1 (es) Compuestos de indanil-piperazina un procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR042343A1 (es) Derivados de pirazina que presentan efecto inhibidor selectivo sobre gsk3, proceso de preparacion y formulaciones farmaceuticas que los contienen
AR042886A1 (es) Derivados de diarilmetilen piperidina, su preparacion y uso de los mismos tanto en composiciones farmaceuticas como en la fabricacion de medicamentos.

Legal Events

Date Code Title Description
FB Suspension of granting procedure